Behavioral Health Business September 4, 2024
After a year and a half of scale-backs and tempered growth, LifeStance Health (Nasdaq: LFST) is planning a return to M&A. The target for that comeback: 2026.
LifeStance is still completing processes designed to improve efficiency, David Bourdon, the company’s chief financial officer, said at the 22nd Annual Morgan Stanley Healthcare Conference on Wednesday. Along those lines, LifeStance maintains its plans to exit 2025 with double-digit margins, he added.
“In the last 18 months, our growth algorithm is primarily a little bit of rate, a lot of clinician growth, which drives the visit volume, and then … some modest productivity improvements,” Bourdon said. “We expect that to continue in 2025 in a low single-digit-rate increase, and then we’ll get the...
Today's Sponsors
Today's Sponsor